Francoise Baylis

On June 30, 2016, Baylis was appointed to the Order of Canada by Governor General David Johnston for "her contributions as a champion of health-care ethics in Canada and for creating forums for discussing current medical-ethics issues." Other awards and honours include:

As a contributor to feminist ethics, Baylis' orientation stresses the political dimensions of doing bioethics, using one's expertise to impact public policy in the hopes of furthering moral and social progress—in the hopes "to make the world a better place." Baylis has authored and co-authored reports for the United Nations Educational, Scientific and Cultural Organization (for example, regarding the status of scientific researchers). As an example of her efforts at shaping public policy, she has prepared expert testimony for a number of Courts and Canadian Parliamentary Committees for a diversity of bioethics issues, including ethics in the context of clinical trials and governance of assisted human reproduction (e.g. The Regulation of Assisted Human Reproductive Technologies and Related Research: A Public Health, Safety and Morality Argument).

Baylis has made numerous contributions to the development of public policy on various assisted human reproduction topics – often the only invited Canadian participant in policy discussions in Europe and elsewhere. Most recently, her reputation garnered an invitation from the US National Academy of Sciences and National Academy of Medicine to join the Planning Committee for an International Summit on Human Gene Editing. Baylis led one of the two Canadian Institutes of Health Research-funded neuroethics teams from 2006–2011. Through that six-year program, she helped to head the development of a new field for Canada. She also co-chaired the first international neuroethics conference (Brain Matters I) in Halifax in 2009, which has developed into an annual or sometimes bi-annual conference ever since. Beyond her research contributions in the realm of assisted reproductive technologies (including contemporary family-making) and women's health in general, Baylis is counted as making contributions to several additional, specific areas of scholarly inquiry:

Baylis has also assumed responsibilities for building and maintaining national and international research communities. She was one of the original co-coordinators and advisory board members, as well as the chair of the nominating committee for Feminist Approaches to Bioethics (FAB) – an international network of feminist bioethics researchers. In this regard, Baylis’ work has helped to ensure a venue for publication of feminist bioethics authors with the International Journal of FAB. Moreover, her efforts on behalf of Feminist Approaches to Bioethics (FAB) have fostered community-building among feminist bioethics academics and practitioners as exemplified through FAB's bi-annual World Congress (held in association with International Association of Bioethics meetings). Baylis has also played a role in fostering and helping to direct the health science research community in Canada. She served on the Governing Councils of the Canadian Biotechnology Advisory Committee (1999-2001), Canadian Institutes of Health Research (2001-2004), and Assisted Human Reproduction Canada (2006-2010). She is known for having advanced the integration of ethics within these agencies and the protection of human research participants. She is also known as an opponent of institutional choices and practices that abet "structural conflict of interest regarding the funding of research and the governance of research ethics."

Since 2011, Baylis has used her second tenure as a Canada Research Chair to focus on "developing new strategies that would allow bioethicists to make just and lasting policy contributions." As coined by Baylis, "impact ethics" is about "question[ing] the status quo in health care", "mak[ing] science subservient to the human good", "mak[ing] public institutions more responsive, accountable, and just", and "critiqu[ing] professional bioethics." Her research projects on "impact ethics" include an emphasis on knowledge translation and mobilization which aim to implement in policy and practice a bioethics that is "responsible", "accountable" and "innovative"—a bioethics that can "make a difference" in serving the public by requiring from those who work in the field to act with "integrity and sensitivity to the real world of healthcare delivery, policy-making and politics." A specific arm of these various projects is the Impact Ethics blog which publishes submissions from a range of authors (students and faculty, academics, and writers outside of academia) with various perspectives on a diversity of subjects for bioethical debate. As Baylis summarizes it: "Impact ethics is about using the tools of ethics to shock, press, crack, and chip society into a better place. It is about outcomes, and ordering the study of ethics around changing things for the better."

Baylis' current academic appointment is with the Faculty of Medicine and she is cross-appointed to the Departments of Obstetrics & Gynaecology and Philosophy (Dalhousie University). Baylis is the founder and leader (since 2003) of Novel Tech Ethics, now renamed NTE Impact Ethics, an interdisciplinary research team based at Dalhousie University (with some international collaborators) that does research at the intersection of health, bioethics, and public policy.

Notable achievements during her career include: being named to the "Who's Who in Black Canada" (2002–present) and to "Canadian Who's Who" (2004–present); three Governor-in-Council appointments, including member of the Canadian Biotechnology Advisory Committee (1999-2001), member of Governing Council, Canadian Institutes of Health Research (2001-2004) and member of the Board of Directors, Assisted Human Reproduction Canada (2006-2010); Royal Society of Canada Academic Secretary (Academy I) and Atlantic Steering Committee Chair (2012-2015); and Canada Research Chair (Tier 1) in Bioethics and Philosophy (2004-2018).

In 1996 Baylis was hired on at Dalhousie University as an Associate Professor in the Office of Bioethics Education and Research (later the Department of Bioethics), and in 2004 became Professor and Canada Research Chair in Bioethics and Philosophy. In 2007, she became an elected Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. She previously served as an Assistant Professor of Philosophy at the University of Tennessee, Knoxville as well as a Lecturer with the Departments of Paediatrics, Obstetrics & Gynaecology, and Rehabilitation Medicine with the University of Toronto (1991-1993) and Department of Obstetrics & Gynaecology with the University of Western Ontario (1989-1991). Her early employment also included working as an Ethics Consultant to the Royal Commission on New Reproductive Technologies and as a Clinical Ethics Consultant at hospitals in London ON, Toronto ON, Knoxville TN, and Halifax NS.

Baylis has been the principal investigator on eleven Canadian Institutes of Health Research (CIHR) grants (totaling more than $2.4 million), including a New Emerging Team grant, States of Mind: Emerging Issues in Neuroethics. In total, since 1990 she has secured greater than $2.8 million in research funding as a Principal Investigator, > $1.8 million as a Co-Principal- or Co-Investigator, and >$2 million as a Collaborator, Project Advisor or Team Member. As such, her track record in getting support for health ethics research is likely to be unusually successful, especially for someone trained in the humanities.

Baylis' education includes a Certificate of Bilingualism from Laurentian University (1981), Political Science degree (BA, First Class Honours) from McGill University (1983), followed by an MA (Philosophy, 1984) and PhD (Philosophy, specialization Bioethics, 1989) from the University of Western Ontario (currently known as Western University). The title of her PhD thesis is "The ethics of ex utero research on spare IVF human embryos" and was completed under the supervision of Benjamin Freedman. In the thesis she introduced (at the time) a "novel ethical distinction between viable and non-viable human embryos." Her concept of "non-viable embryos" as acceptable objects for research is still referenced today.

Françoise Elvina Baylis CM ONS FRSC FCAHS (born 1961) is a Canadian bioethicist whose work is at the intersection of applied ethics, health policy, and practice. The focus of her research is on issues of women's health and assisted reproductive technologies, but her research and publication record also extend to such topics as research involving humans (including human embryo research), gene editing, novel genetic technologies, public health, the role of bioethics consultants, and neuroethics. Baylis' interest in the impact of bioethics on health and public policy as well as her commitment to citizen engagement and participatory democracy sees her engage with print, radio, television, and other online publications.